The appropriateness of existing methodologies to assess the

0,23

MB

potential risks associated with engineered and adventitious

40

stron

products of nanotechnologies

6328

ID

Scientific Committee on Emerging and Newly Identified Health Risks

2006

rok

(SCENIHR)

EXECUTIVE SUMMARY

1. Background 5

2. Public consultation . 6

2.1 Responses to the Consultation 6

2.2 General observations made by respondents 7

2.3 Key Issues arising from the public consultation 9

2.3.1 Appropriateness of existing risk assessment methodologies 9

2.3.2 New and modified methodologies for risk assessment . 10

2.3.3 Information gaps . 11

3. Conclusions 12

ANNEX I A Summary of the comments and the SCENIHR responses